Home› Europe› EEA Joint Committee› Decision of the EEA Joint Committee No 84/2023 of 28 April 2...
Date: 2023-11-09 Category: Not Applicable State: Union Government Country: Europe

Decision of the EEA Joint Committee No 84/2023 of 28 April 2023 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/2239]

Issued by EEA Joint Committee · Not Applicable

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

Executive Summary: This EEA Joint Committee Decision No. 84/2023 amends Annex II to the EEA Agreement to incorporate several Commission Implementing Decisions related to biocidal products. The decisions concern the postponement of expiry dates for approvals of certain substances and the resolution of objections regarding authorization conditions for specific biocidal products. The decision entered into force on April 29, 2023, following notifications under the EEA Agreement. Key Points / Main Content: Incorporation of Commission Implementing Decisions: * The following Commission Implementing Decisions are incorporated into Annex II of the EEA Agreement: * (EU) 2022/1484: DDACarbonate (product-type 8) approval expiry postponement * (EU) 2022/1486: Acrolein (product-type 12) approval expiry postponement * (EU) 2022/1487: Etofenprox (product-type 8) approval expiry postponement * (EU) 2022/1488: KHDO (product-type 8) approval expiry postponement * (EU) 2022/1489: Spinosad (product-type 18) approval expiry postponement * (EU) 2022/1494: Unresolved objections for Mouskito Spray authorization * (EU) 2022/1495: Medetomidine (product-type 21) approval expiry postponement * (EU) 2022/1496: Tebuconazole (product-type 8) approval expiry postponement * (EU) 2022/1497: Determination of Capsicum oleoresin expeller pressed as a biocidal product * (EU) 2022/1515: Unresolved objections for Mouskito Junior Lotion authorization Authentic Language: * The Icelandic and Norwegian language texts of the listed Implementing Decisions will be published in the EEA Supplement to the Official Journal of the European Union and are authentic. Entry into Force: * The Decision came into force on April 29, 2023, after all notifications under Article 103(1) of the EEA Agreement were made. Publication: * The Decision will be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union. Impact Analysis: EEA Member States: Impact: National authorities are now obligated to implement the incorporated Commission Implementing Decisions regarding biocidal products. Action Required: Update national regulations and procedures to reflect the changes introduced by the incorporated decisions. Biocidal Product Manufacturers and Distributors: Impact: Companies dealing with the specified biocidal products (containing DDACarbonate, acrolein, etofenprox, KHDO, spinosad, medetomidine, tebuconazole, or Capsicum oleoresin expeller pressed) are affected by the changes in approval expiry dates and authorization conditions. Action Required: Adjust product formulations, labeling, and marketing strategies to comply with the updated regulations and authorization conditions. Applicants for Biocidal Product Authorizations: Impact: The decisions on unresolved objections for Mouskito Spray and Mouskito Junior Lotion directly affect the authorization process for these products. Action Required: Address the unresolved objections and provide any additional information or data requested by the relevant authorities to facilitate the authorization process.

Key Entities Referenced

EEA Joint Committee: The governing body responsible for managing the EEA Agreement. EEA Agreement: The Agreement on the European Economic Area. Annex II Technical regulations, standards, testing and certification to the EEA Agreement: A section of the EEA Agreement that is being amended by this decision. Regulation EU No 528/2012: A regulation of the European Parliament and of the Council concerning the making available on the market and use of biocidal products. Commission Implementing Decision EU 2022/1484: A Commission Implementing Decision postponing the expiry date of the approval of DDACarbonate. Commission Implementing Decision EU 2022/1494: A Commission Implementing Decision on the unresolved objections regarding the conditions for granting an authorisation for the biocidal product Mouskito Spray. Nicolas VON LINGEN: The President of the EEA Joint Committee. Brussels: The city where the EEA Joint Committee decision was made.
Official Source Record View Original Source →
See Full Document Text
Official Journal EN of the European Union L series 2023/2239 9.11.2023 DECISION OF THE EEA JOINT COMMITTEE No 84/2023 of 28 April 2023 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/2239] THE EEA JOINT COMMITTEE, Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof, Whereas: (1) Commission Implementing Decision (EU) 2022/1484 of 7 September 2022 postponing the expiry date of the approval of DDACarbonate for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(1)is to be incorporated into the EEA Agreement. (2) Commission Implementing Decision (EU) 2022/1486 of 7 September 2022 postponing the expiry date of the approval of acrolein for use in biocidal products of product-type 12 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(2)is to be incorporated into the EEA Agreement. (3) Commission Implementing Decision (EU) 2022/1487 of 7 September 2022 postponing the expiry date of the approval of etofenprox for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(3)is to be incorporated into the EEA Agreement. (4) Commission Implementing Decision (EU) 2022/1488 of 7 September 2022 postponing the expiry date of the approval of K-HDO for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(4)is to be incorporated into the EEA Agreement. (5) Commission Implementing Decision (EU) 2022/1489 of 7 September 2022 postponing the expiry date of the approval of spinosad for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(5)is to be incorporated into the EEA Agreement. (6) Commission Implementing Decision (EU) 2022/1494 of 7 September 2022on the unresolved objections regarding the conditions for granting an authorisation for the biocidal product Mouskito Spray in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(6)is to be incorporated into the EEA Agreement. (7) Commission Implementing Decision (EU) 2022/1495 of 8 September 2022 postponing the expiry date of the approval of medetomidine for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(7)is to be incorporated into the EEA Agreement. (8) Commission Implementing Decision (EU) 2022/1496 of 8 September 2022 postponing the expiry date of the approval of tebuconazole for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(8)is to be incorporated into the EEA Agreement. (1) OJ L 233, 8.9.2022, p. 79. (2) OJ L 233, 8.9.2022, p. 83. (3) OJ L 233, 8.9.2022, p. 85. (4) OJ L 233, 8.9.2022, p. 87. (5) OJ L 233, 8.9.2022, p. 89. (6) OJ L 234, 9.9.2022, p. 23. (7) OJ L 234, 9.9.2022, p. 26. (8) OJ L 234, 9.9.2022, p. 28. ELI: http://data.europa.eu/eli/dec/2023/2239/oj 1/3EN OJ L, 9.11.2023 (9) Commission Implementing Decision (EU) 2022/1497 of 8 September 2022 determining whether a product containing ‘Capsicum oleoresin expeller pressed’ is a biocidal product, pursuant to Article 3(3) of Regulation (EU) No 528/2012 of the European Parliament and of the Council(9)is to be incorporated into the EEA Agreement. (10) Commission Implementing Decision (EU) 2022/1515 of 8 September 2022on the unresolved objections regarding the conditions for granting an authorisation for the biocidal product Mouskito Junior Lotion in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(10)is to be incorporated into the EEA Agreement. (11) Annex II to the EEA Agreement should therefore be amended accordingly, HAS ADOPTED THIS DECISION: Article 1 The following points are inserted after point 12zzzzzzzzd (Commission Implementing Decision (EU) 2022/874) of Chapter XV of Annex II to the EEA Agreement: ‘12zzzzzzzze. 32022 D 1484: Commission Implementing Decision (EU) 2022/1484 of 7 September 2022postponing the expiry date of the approval of DDACarbonate for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 233, 8.9.2022, p. 79). 12zzzzzzzzf. 32022 D 1486: Commission Implementing Decision (EU) 2022/1486 of 7 September 2022postponing the expiry date of the approval of acrolein for use in biocidal products of product-type 12 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 233, 8.9.2022, p. 83). 12zzzzzzzzg. 32022 D 1487: Commission Implementing Decision (EU) 2022/1487 of 7 September 2022postponing the expiry date of the approval of etofenprox for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 233, 8.9.2022, p. 85). 12zzzzzzzzh. 32022 D 1488: Commission Implementing Decision (EU) 2022/1488 of 7 September 2022postponing the expiry date of the approval of K-HDO for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 233, 8.9.2022, p. 87). 12zzzzzzzzi. 32022 D 1489: Commission Implementing Decision (EU) 2022/1489 of 7 September 2022postponing the expiry date of the approval of spinosad for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 233, 8.9.2022, p. 89). 12zzzzzzzzj. 32022 D 1494: Commission Implementing Decision (EU) 2022/1494 of 7 September 2022 on the unresolved objections regarding the conditions for granting an authorisation for the biocidal product Mouskito Spray in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 234, 9.9.2022, p. 23). 12zzzzzzzzk. 32022 D 1495: Commission Implementing Decision (EU) 2022/1495 of 8 September 2022postponing the expiry date of the approval of medetomidine for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 234, 9.9.2022, p. 26). 12zzzzzzzzl. 32022 D 1496: Commission Implementing Decision (EU) 2022/1496 of 8 September 2022postponing the expiry date of the approval of tebuconazole for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 234, 9.9.2022, p. 28). (9) OJ L 234, 9.9.2022, p. 30. (10) OJ L 235, 12.9.2022, p. 58. 2/3 ELI: http://data.europa.eu/eli/dec/2023/2239/ojEN OJ L, 9.11.2023 12zzzzzzzzm. 32022 D 1497: Commission Implementing Decision (EU) 2022/1497 of 8 September 2022determining whether a product containing ‘Capsicum oleoresin expeller pressed’ is a biocidal product, pursuant to Article 3(3) of Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 234, 9.9.2022, p. 30). 12zzzzzzzzn. 32022 D 1515: Commission Implementing Decision (EU) 2022/1515 of 8 September 2022 on the unresolved objections regarding the conditions for granting an authorisation for the biocidal product Mouskito Junior Lotion in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 235, 12.9.2022, p. 58).’ Article 2 The texts of Implementing Decisions (EU) 2022/1484, (EU) 2022/1486, (EU) 2022/1487, (EU) 2022/1488, (EU) 2022/1489, (EU) 2022/1494, (EU) 2022/1495, (EU) 2022/1496, (EU) 2022/1497 and (EU) 2022/1515 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic. Article 3 This Decision shall enter into force on 29 April 2023, provided that all the notifications under Article 103(1) of the EEA Agreement have been made*. Article 4 This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union. Done at Brussels, 28 April 2023. For the EEA Joint Committee The President Nicolas VON LINGEN * No constitutional requirements indicated. ELI: http://data.europa.eu/eli/dec/2023/2239/oj 3/3

Continue your research

Related Documents from EEA Joint Committee